Angiodysplasia primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angiodysplasia}}
{{Angiodysplasia}}
{{CMG}} {{AE}} {{NKS}}
{{CMG}}; {{AE}} {{NKT}}


==Primary Prevention==
==Primary Prevention==

Latest revision as of 10:55, 15 October 2021

Angiodysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiodysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiodysplasia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiodysplasia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiodysplasia primary prevention

CDC on Angiodysplasia primary prevention

Angiodysplasia primary prevention in the news

Blogs on Angiodysplasia primary prevention

Directions to Hospitals Treating Angiodysplasia

Risk calculators and risk factors for Angiodysplasia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]

Primary Prevention

No method for primary prevention of angiodysplasia has been recognized till date. Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) should be avoided due to its potentially damaging effects on both upper and lower GI.[1]

References

  1. Sostres C, Gargallo CJ, Lanas A (2013). "Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage". Arthritis Res Ther. 15 Suppl 3: S3. doi:10.1186/ar4175. PMC 3890944. PMID 24267289.

Template:WS Template:WH